Innovation for Your Health

All news from Hamburg
and Schleswig-Holstein


Evotec expands its iPSC discovery platform

Evotec SE announced that the Company has acquired assets from the stem cell specialist Ncardia AG to advance Evotec’s iPSC platform, one of the leading iPSC-based discovery platforms in the industry....


New IMI project “GNA NOW” kicks off its battle against antimicrobial resistance

Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents: Gram-Negative Antibacterials NOW (“GNA NOW”). The new GNA NOW project, led by...


Evotec and venture capital consortium form "Breakpoint Therapeutics GmbH"

Evotec SE announced the formation of Breakpoint Therapeutics GmbH, a spin-off company focusing on the development of Evotec’s DNA damage response (“DDR”) portfolio, comprising discovery-stage assets...


CORNET issues Calls for Proposals

The 28th CORNET Call for Proposals is now OPEN! Submission is possible until 25 September 2019, 12 p.m. (CET) via the Submission Tool. Twice a year, CORNET issues Calls for Proposals for...


Evotec create a new bridge partnership in digital health

Evotec SE announced that it has entered into a new strategic partnership with the British clinical AI technology company Sensyne Health plc (LSE:SENS) (“Sensyne”), the University of Oxford, Oxford...


Evotec receives $ 23.8 m grant to join the global fight against tuberculosis

Evotec SE announced that the company has entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens that better address tuberculosis (“TB”), a...


Evotec acuires Just Biotherapeutics

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based earn-out...


Eppendorf with worldwide setting program

The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company...


Breaking ground for the Innovation Centre

The mayor of Hamburg, Dr. Peter Tschentscher, symbolically broke the ground together with his deputy, the Senator for Science Katharina Fegebank, the Chairman of DESY’s Board of Directors, Dr. Helmut...


Evotec and Indivumed announce collaboration for colorectal cancer

Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer (“CRC”). The...

© Copyright Life Science Nord e.V.

All rights reserved. Especially reprint, incorporation in online services, internet and amplification using data vehicles like CD-Rom, DVD-ROM etc. even in extracts require written permission by Life Science Nord e.V. Life Science NOrd e.V. is not responsible for content of external links and and foreign contents.

In case you would like to use our newsletter via email as a free-of-charge and effective PR tool, please send us your company news that we eill publish in the following issue. Profit from this communication platform, make new contacts and take care of existing ones.


Simone Hauck
PR & Communications Manager

P +49.40.471 96-423


  • Desitin

Content loading failure